GoConqr has a new look! Let us know what you think.

Flashcards

Enterics II

Kerra Washington English 88 cards

Cards in this deck (88)

  1. 1What are the microbiological features of Salmonella?- gram-negative rods
    - facultative anaerobes
    - oxidase negative
    - lactose negative
    - motile (phase variable)
    - hydrogen sulfide producers
  2. 2What are types of Salmonella host ranges?broad and narrow
  3. 3broad-host-range Salmonellainfect diverse animal species; typically cause gastroenteritis in humans
  4. 4What are the Salmonella serotypes with a broad-host-range?S. Typhimurium
    S. Enteritidis
  5. 5narrow-host-range Salmonellaspecifically adapted to a preferred host and rarely manifest as gastroenteritis
  6. 6What are the diseases caused by non-Typhoid serotype Salmonella?gastroenteritis and bacteremia
  7. 7What are the symptoms of gastroenteritis?medium volume, watery diarrhea
    fever
    nausea
    vomiting
  8. 8What are the clinical characteristics of gastroenteritis?- 12-48 hour incubation period (longer with a lower infectious dose
    - 3-7 day duration
    - self-resolving
    - carriage in stool 4-5 weeks post-resolution
  9. 9What are the clinical characteristics of bacteremia?- approx. 8% of patients with non-typhoidal salmonellosis
    - secondary focal infections in 5-10% of cases (adults)
    - AIDS patients at high risk (recurrent bacteremia AIDS-defining)
    - host adapted serotypes S. Choleraestitis & S. Dublin (have higher propensity often without antecedent gastroenteritis
  10. 10What is the incidence of non-typhoidal serotype Salmonella in the US?- 40-50,000 reported cases/yr (1-1.5 million actual)
    - highest incidence: in children < 5 yrs old & elderly
    - seasonal pattern: late summer, early fall
  11. 11How is non-typhoidal serotype Salmonella transmitted?contaminated food and water
    eggs and poultry most commonly
    a vast array of foods
  12. 12What is the infectious dose of non-typhoidal serotype Salmonella?10^6 to 10^8
  13. 13How is non-typhoidal serotype Salmonella isolated and identified?1. plate fecal specimen on selective/differential media
    2. biochemical test of lac negative isolates
    3. determine serotype
  14. 14What is the treatment and prevention of non-typhoidal serotype Salmonella?- fluid & electrolyte replacement
    - antimicrobial treatment (1. non therapeutic value for uncomplicated gastroenteritis and 2. preemptive treatment of patients at high risk of bacteremia)
    - proper food preperation & storage prevents infection
  15. 15What are the diseases associated with typhoidal serotype Salmonella?enteric (typhoid) fever and chronic asymptomatic carriage
  16. 16What are the clinical characteristics of enteric (typhoid) fever?- severe systemic illness with protracted (3-4 weeks)
    - insidious onset, headache, anorexia, myalgia 10-14 days post-exposure
    - gastroenteritis symptoms ~ 1 week later
    - occasional maculopapular rash on trunk "rose spots"
    - 10-15% mortality in untreated cases
    - milder cases with S. Paratyphi
  17. 17What are the clinical characteristics of chronic asymptomatic carriage?- excretion of the organism in stool for >1 yr
    - 1-4% of untreated typhoid patients
    - gallbladder primary reservoir
  18. 18How are S. Typhi and S. Paratyphi (typhoidal serotype) transmitted?fecal contamination of food and water
  19. 19What is the reservoir of S. Typhi and S. Paratyphi (typhoidal serotype Salmonella)?humans
  20. 20What is the US incidence of S. Typhi and S. Paratyphi (typhoidal serotype Salmonella)?400-500 cases/yr
    75% traveler's disease
  21. 21What is the global incidence of S. Typhi and S. Paratyphi (typhoidal serotype Salmonella)?~10-20 million cases/yr (80% caused by S. Typhi)
    ~200,000 deaths/yr
  22. 22What are the treatment and preventative measures for typhoid serotype Salmonella"?- fluid & electrolyte replacement
    - antimicrobial treatment (reduces complications and mortality/variable sensitivity)
    - proper sanitation and water treatment
    - vaccine recommended for traveler
  23. 23What is the vaccine for typhoid serotype Salmonella?Typbar-TCV
  24. 24What is Typbar-TCV and its properties?Vi capsule polysaccharide conjugated to tetanus toxoid
    - infants
    - long lasting
    - prequalified by WHO in 2017
  25. 25What are the microbiological features of the genus Yersinia?- gram negative rod
    - facultative anaerobe
    - oxidase negative
    - lactose negative
    - bipolar staining
    - nonmotile @ 37 degrees Celcius
    - motile @ 25 degrees Celcius
    psychrophilic (grow @ 4 degrees Celcius)
  26. 26What are the clinically significant species of Yersinia?- Yersinia enterocolitica
    - Yersinia pseudoturberculosis
    - Yersinia pestis
  27. 27What is the reservoir of Y. enterocolitis and Y. pseudotuberculosis?wild and domestic animals and environment
  28. 28What is the common transmission vehicles of Y. enterocolitis and Y. pseudotuberculosis?raw uncooked pork
    unpasteurized milk/milk products
    stored blood - 2 cases/year
  29. 29What is the incidence and epidemiology of Y. enterocolitis and Y. pseudotuberculosis?more common in colder climates (Canada, Northern Europe)
    most cases in children
    serotypes O3 & O9 in Europe
    serotype O3 in Canada
    serotype O8 in the US
    ~ 150 confirmed cases/yr in US
  30. 30What is the pathogenicity of Y. enterocolitis and Y. pseudotuberculosis?can survive in macrophages
    similar to S. Typhi
  31. 31What are the microbiological features of the genus Vibrio?- gram negative curved rod
    - single polar flagella
    - facultative anaerobes
    - oxidase positive (distinguishes from Enterobacteriaceae
    - most species are halophilic (except V. cholera)
  32. 32halophilicrequires high salt concentration for growth
  33. 33What are the clinically significant species of Vibrio?V. cholera
    V. parahaemolyticus
    V. vulnificus
  34. 34What is unique about the genome of V. cholerae?bipartite genome
  35. 35What is a bipartite genome?the genome is segmented into two segments (referred to as DNA A and DNA B) that are packaged into separate particles
    - essential genes on each segment
  36. 36What is the clinical presentation of V. cholera?- asymptomatic to severe, rapidly fatal, dehydrating diarrhea
    - characterized by rice-water stool
    - extensive fluid & electrolyte loss leading to hypovolemic shock, hypokalemia, and metabolic acidosis
    - mortality up to 60% if untreated
    - mortality < 1% with treatment
  37. 37hypovolemicdecreases blood volume
  38. 38hypokalemiadecreased potassium levels
  39. 39metabolic acidosislow blood pH
  40. 40What is the reservoir of V. cholera?estuarine environment
  41. 41What are the transmission vehicles of V. cholerae?contaminated water and food (sea food)
  42. 42What is the infectious dose of V. cholerae?~ 10x8 bacteria
  43. 43What is the incidence of V. cholerae?US: low, 2-13 cases/yr - traveler's disease
    global: > 500,000 cases reported/yr
    endemic regions - symptomatic cases 2-15 yr olds
    epidemic regions - all age groups at risk
    7 pandemics since 1817
  44. 44What is the strain (serotype) association of pandemics and epidemics of V. cholerae?- all prior pandemics and epidemics due to serotype O1 (Yemen)
    - epidemic ~ 20 yrs ago secondary to serotype O139 (Bengal)
  45. 45What is the name of the phage that encodes the pathogenicity of V. cholerae?CTX phi
  46. 46What does the V. cholerae phages encode for and its characteristics?encodes cholera toxin
    binds TCP pilus
    absent from most environmental isolates
    viable non-culturable
  47. 47What are the diagnostics techniques used to identify V. cholerae?- movement of the bacteria via darkfield microscopy
    - culture fecal specimens on TCBS agar
    - fluorescent antibodies
    - biochemical verification and serotype O1 & O139
  48. 48What is the treatment for V. cholerae?- fluid & electrolyte replacement
    - antibiotics reduce the duration of symptoms and shedding
    - antibiotic sensitivity varies
  49. 49What are the preventative measures of V. cholerae?- proper sanitation and water treatment facilities
    - oral vaccines
  50. 50What are the oral vaccines of V. cholerae?- DUKORAL
    -Shanchol/mORCVAX/Euvichol
    -Vaxchora
  51. 51What is DUKORAL?killed whole cell w/recombinant B subunit for serotype O1 strains
    - 60% efficacy
  52. 52What is Shanchol/mORCVAX/Euvichol?killed whole cells for serotypes O1 and O139
  53. 53What is Vaxchora?live attenuated oral vaccine
    FDA approved in 2016
  54. 54What are the clinical presentations of V. parahaemolyticus?- explosive watery diarrhea (sometimes bloody)
    - a headache
    - cramps
    -nausea
    - occasionally septicemia
  55. 55What is the treatment of V. parahaemolyticus?self-resolving
  56. 56What is the reservoir for V. parahaemolyticus?marine environment
  57. 57What is the transmission route of V. parahaemolyticus?raw sea food
  58. 58What is the prominent serotype of V. parahaemolyticus and where is it geographically located?O3:K6
    Japan
  59. 59What are the two toxins that V. parahaemolyticus produces?TDH
    TRH
  60. 60What is TDH and what bacteria produces it?thermostable direct hemolysin
    V. parahaemolyticus
  61. 61What is TRH and what bacteria produce it?TDH-related hemolysin
    V. parahaemolyticus
  62. 62What are the human infections that occur from V. vulnificus?- rapidly progressing necrotic wound infections
    - fulminant septicemia
  63. 63What is the epidemiology of fulminant septicemia in those exposed to V. vulnificus?- 50% mortality
    - 80% occurrence in male
    - 93% occurs with consumption of raw oysters
    - 95% of those infected have pre-existing liver conditions
  64. 64How are those commonly infected with V. vulnificus?fishmongers
    oyster shuckers
    results of occupational hazard
  65. 65What are the other species of Vibrio cause infections in humans?V. alginolyticus
    V. hollisae
    V. mimicus
    V. fluvialis
    V. furnissii
    V. damsela
  66. 66What are the microbiological features of the genus Campylobacter?- gram negative
    - 0.3-0.6 micron diameter
    - curved/helical rod
    - single polar flagellum
    - microaerophilic (5-7% oxygen)
    - oxidative metabolism (do not utilize carbohydrates)
    - optimal growth at 42 degrees (some species)
    - oxidase positive
    - polysaccharide capsule (phase variable)
  67. 67What is the disease presentation of Campylobacter infection?bloody diarrhea
    abdominal cramping
    frequent bowel movements (~10-20/day)
    last for about 3-4 days
    self-resolving
  68. 68What are the transmission vehicles of Campylobacter?undercooked poultry
    raw milk
    surface water
    beef, clams, and cheese
    direct contact with infected animals & pets
  69. 69What is the US incidence of Campylobacter?~ 1.5-2 million vases/yr
    seasonal, summer to early fall
    higher in rural communities
  70. 70What is the global incidence of Campylobacter?pervasive
    symptomatic in children
    asymptomatic in adults
  71. 71What genus of bacteria rivals Campylobacter in disease incidence in the U.S.?Salmonella
  72. 72What are the sequalae diseases associated with a Campylobacter infection?- Guillain-Barre syndrome
    - reactive arthritis
    - inflammatory bowel disease
  73. 73What is Guillain-Barre syndrome and its epidemiology?flaccid peripheral neuropathy due to inflammatory demyelination
    - approx. 1 in 2000 C. jejuni infections
    - 30-66% of cases have previous C. jejuni infections
    -sialic acid containing LOS
  74. 74What occurs secondary to sialic acid-containing LOS?induces cross-reactive antibodies
    "molecular mimicry"
  75. 75What is LOS stand for and mean?lipodigosaccharide
    similiar to LPS, but lacking outer O-antigen repeats
  76. 76What are the isolation and identification methods of Campylobacter?1. direct examination of feces
    2. culture stools (blood)
    3. bacteriological filter which has a very small diameter
  77. 77What is the treatment and prevention for a Campylobacter infection?- self-resolving
    - fluid and electrolyte replacement
    - anitmicrobioal treatment in severe cases and bacteremic patients
    - prevented by proper hygeine and food preperation
  78. 78Why is the treatment of a Campylobacter infection with vaccines problematic?- > 90 somatic O antigents
    -resistant to quinolones
  79. 79What are the microbiological features of Helicobacter?- gram negative helical rod
    - motile by polar flagella
    - microaerophilic
    - urease positive
    - oxidase positive
    - high genetic variability
  80. 80What is the disease presentation of H. pylori?- results in life long gastric colonization
    - initial acquisition can be asymptomatic or cause gastritis
    - main cause of gastric ulcers
  81. 81What is the reservoir for H. pylori?humans
  82. 82How is H. pylori transmitted?fecal-oral & oral-oral
    clusters within family
  83. 83What is the US incidence of H. pylori infection?- increase with age
    - inversely related to socio-economic status
  84. 84What is the global incidence of a H. pylori infection?- >70% carriage by age 10 in developing regions
  85. 85What is a possible occurrence with treatment of H. pylori?can cause esophageal reflux that can cause esophageal cancer
  86. 86What is the only bacterium that is considered to be a gastric carcinogen?H. pylori
  87. 87What are the isolation and identification methods for H. pylori?1. histological examination of gastric biopsy (gold standard, but invasive)
    2. culture of biopsy on specialized media (2 week incubation period)
    3. urease test via biopsy or breath test (isotopically labeled CO2)
    4. stool antigen tests (commercially available)
  88. 88What are the treatment and prevention methods of H. pylori?-7-10 day regimen with proton pump inhibitor, macrolide and beta lactam
    - benefit/risk assessment

Information

Description
Flashcards on Enterics II, created by Kerra Washington on 06/11/2018.
Created by
Kerra Washington · Nov 2018
Updated
Nov 12, 2018
Views
1
Rating

Feedback

What is it about?

What do you think of the new look?

How do you like it?